We are live on ! Find out more
BSX icon

Boston Scientific

842 hedge funds and large institutions have $45.9B invested in Boston Scientific in 2020 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 358 increasing their positions, 245 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 114 | Existing positions closed: 67

46% more repeat investments, than reductions

Existing positions increased: 358 | Existing positions reduced: 245

27% more capital inflows, than outflows

Capital inflows: $5.34B | Capital outflows: $4.22B

5% more funds holding

Funds holding: 802 → 842 (+40)

0.19% more ownership

Funds ownership: 91.19% → 91.39% (+0.19%)

26% less funds holding in top 10

Funds holding in top 10: 23 → 17 (-6)

42% less call options, than puts

Call options by funds: $207M | Put options by funds: $357M

Holders
842
Holders Change
+40
Holders Change %
+4.99%
% of All Funds
17.22%
Holding in Top 10
17
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-26.09%
% of All Funds
0.35%
New
114
Increased
358
Reduced
245
Closed
67
Calls
$207​M
Puts
$357​M
Net Calls
-⁠$150​M
Net Calls Change
-⁠$117​M

BSX Hedge Fund Activity: Q2 2020 in Review

842 of the 4,891 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2020, worth a combined $45.9B — up 10% from $41.7B a quarter earlier.

Buyers outnumbered sellers: 114 funds opened new BSX positions and 67 closed out — a net gain of 47 holders — while 358 added to existing stakes and 245 trimmed.

The largest buyer was BlackRock, adding an estimated $628M. The largest seller was Fidelity Investments, cutting an estimated $1.26B.

  • 842 institutional investors held Boston Scientific (BSX) as of Q2 2020, up from 802 in Q1 2020.
  • Funds reported $45.9B of Boston Scientific stock for Q2 2020, up 10% quarter-over-quarter.
  • 114 funds opened new Boston Scientific positions in Q2 2020 and 67 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q2 2020 was BlackRock, an estimated $628M added.
  • The largest Boston Scientific seller in Q2 2020 was Fidelity Investments, an estimated $1.26B sold.

Based on aggregated 13F filings for Q2 2020.